Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Vitamin D Status Correction and Validation of its Potential Clinical Utility through Discovery Proteomic Analysis | Prince Mutaib Chair for Biomarkers of Osteoporosis/synergypha-rma | Completed | cholecalciferol | 3 | E-15-1667 | KKUH |
| Vitamin D status and Covid-19 in Saudi Settings: A randomized open-label study on the possible role of vitamin D on improving clinical outcomes | KKUH | Ongoing | VITA-D | 3 | H-01-R-012 | King Fahad Medical City (Riyadh) |
| Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers | Qassim University | Completed | Vitamin C (ascorbic acid ) Cevital | 3 | 20111803 | Mental Health Hospital (Abha) |
| V212-001 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy | MSD | Completed | V212 | 3 | V212-011 | KFSH |
| Treatment of Neuroendocrine Tumors (NETs) with combination of Everolimus and Radiolabeld Somatostatin Analogue" | King Faisal Specialist Hospital and Research Centre | Ongoing | Everolimus | 2 | ONC-CRC 12- 12 or (RAC # 2121 159) | KFSH & RC-R |
| "Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo controlled trial" | London School of Hygiene & Tropical Medicine (LSHTM) | Ongoing | (Cyklokapron) Tranexamic Acid | 3 | ISRCTN15088122 | KSMC |
| "Tranexamic acid for the treatment of gastrointestinal hemorrhage: an international randomized, double-blind, placebo-controlled trial" | Prince Mohammad Bin Abdulaziz Hospital | Ongoing | Tranexamic acid | 3 | ISRCTN11225767 | PMBAH |
| Tocilizumab Efficacy and Safety in RA Patients After Inadequate Response to DMARDs or Anti-TNF | Roche | Completed | Tocilizumab | 3 | ML22726 | KFSH |
| THydroxychloroquine versus Standard of Care for the Management of COVID-19 | King Abdulaziz University Hospital | Completed | Hydroxychloroquine sulphate | 3 | 249-20 | KAUH-J |
| Therapeutic Effects of Colchicine in the Treatment of Symptomatic and Acute Respiratory Distress Syndrome in COVID-19 Patients | KACST | Completed | Colchicine | 3 | 5200107 | DCH |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.